QSAM Biosciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Common Stock, Preferred Stock and Warrants (Details Narrative)

Common Stock, Preferred Stock and Warrants (Details Narrative) - USD ($)												1 Months Ended		12 Months Ended
	Oct. 02, 2016	Jul. 27, 2016	Jul. 02, 2016	Jun. 22, 2016	Apr. 08, 2016	Mar. 15, 2016	Mar. 11, 2016	Feb. 02, 2016	Jan. 11, 2016	Jan. 02, 2016	Jul. 02, 2014	Aug. 16, 2016	Aug. 09, 2016	Dec. 31, 2016	Dec. 31, 2015	Sep. 23, 2015
Number of restricted stock shares of common stock issued						100,000								3,027,204
Number of restricted stock shares of common stock value						$ 26,000								$ 678,609
Debt conversion shares issued, value														$ 270,750
Debt conversion shares issued														1,289,285
Debt instrument term						120 days
Convertible preferred stock issued during period, shares									100
Convertible preferred stock issued during period, value									$ 100,000
Convertible preferred stock conversion price per share														$ 0.21
Preferred stock dividend percentage			6.00%											6.00%
Warrant term											5 years			5 years
Exercise price of warrants											$ 2.45			$ 0.50		$ 0.21
Convertible preferred stock consent percentage														67.00%
Convertible preferred stock term														2 years
Unamortized discount											$ 20,750			$ 126,217	184,764
Interest expense related to preferred stock discount														137,585	$ 13,492
March 2017 [Member]
Debt conversion shares issued, value														$ 1,500,000
Convertible preferred stock conversion price per share														$ 0.15
Vendors [Member]
Number of restricted stock shares of common stock issued										187,919
Number of restricted stock shares of common stock value										$ 49,859
Two Debenture Holders [Member]
Debt conversion shares issued, value								$ 40,000				$ 167,750
Debt conversion shares issued								190,476				798,809
Three Key Employees [Member]
Number of restricted stock shares of common stock issued										450,000
Number of restricted stock shares of common stock value										$ 117,000
One Debenture Holders [Member]
Debt conversion shares issued, value				$ 31,500			$ 31,500
Debt conversion shares issued				150,000			150,000
Consultant [Member]
Number of restricted stock shares of common stock issued					100,000
Number of restricted stock shares of common stock value					$ 26,000
Affiliated Vendor [Member]
Number of restricted stock shares of common stock issued		50,000
Number of restricted stock shares of common stock value		$ 10,500
Six Accredited Investors [Member]
Number of restricted stock shares of common stock issued													750,000
Number of restricted stock shares of common stock value													$ 157,500
Restricted common stock price per share													$ 0.21
Consultant Services [Member]
Number of restricted stock shares of common stock issued	100,000
Number of restricted stock shares of common stock value	$ 21,000
Accredited Investor [Member]
Convertible preferred stock issued during period, shares														500
Convertible preferred stock issued during period, value														$ 500,000